Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.090
+0.020 (1.87%)
May 2, 2025, 4:00 PM EDT - Market closed
RANI Stock Forecast
RANI's stock price has decreased by -82.89% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for RANI stock have an average target of 11.33, with a low estimate of 9.00 and a high estimate of 17. The average target predicts an increase of 939.45% from the current stock price of 1.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 3, 2025.
Analyst Ratings
The average analyst rating for RANI stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +725.69% | Apr 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +725.69% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +725.69% | Feb 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +725.69% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +725.69% | Oct 18, 2024 |
Financial Forecast
Revenue This Year
255.00M
from 1.03M
Increased by 24,705.45%
Revenue Next Year
8.87M
from 255.00M
Decreased by -96.52%
EPS This Year
-0.96
from -1.05
EPS Next Year
-0.73
from -0.96
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.1B | 45.6M | 124.7M | ||
| Avg | 255.0M | 8.9M | 30.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102,040.1% | -82.1% | 1,306.2% | ||
| Avg | 24,705.4% | -96.5% | 241.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.65 | -0.51 | 0.86 | ||
| Avg | -0.96 | -0.73 | -0.32 | ||
| Low | -1.59 | -0.99 | -1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.